Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Non Operating Income (2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Other Non Operating Income for 1 consecutive years, with -$128000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income changed N/A to -$128000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$463000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$463000.0 for FY2025, N/A changed from the prior year.
  • Other Non Operating Income for Q4 2025 was -$128000.0 at Madrigal Pharmaceuticals, up from -$293000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was -$42000.0 in Q2 2025, with the low at -$293000.0 in Q3 2025.